PharosAI, a UK cancer AI consortium, has received Innovate UK funding for a project called DESTINY that asks whether AI…
A new ARPA-H program aims to simulate trials in silico and cut the number of patients needed.
A five-year federal project will build digital twins that track a critically ill patient's immune state hour by hour.
Ono Pharma will use Aitia's causal AI digital twins to find new drug targets in neurological disease.
Nature Biotechnology reports that FDA's push to reduce animal testing has fueled a boom in AI biosimulation and digital twin…
OCTCube-M reads full volumetric OCT scans to improve retinal disease detection, cut trial sizes and open a window to systemic…
Digital twins and multi-agent virtual scientists are accelerating the FDA's push to reduce animal testing.